Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Faulding receives approval for generic contrast media

Dec. 13, 1996

BioProCon to market DiagnoCure bladder cancer diagnostic

Dec. 13, 1996

ADAC's Molecular Coincidence Detection shows promising results

Dec. 13, 1996

First approval for Pharmacyclics' MRI contrast agent

Dec. 12, 1996

Oncor issued U.S. patent on technology for early detection of breast cancer

Dec. 12, 1996

Boehringer Mannheim markets HGV diagnostic developed under collaboration with Genelabs

Dec. 12, 1996

GastroMARK approved for marketing by FDA

Dec. 12, 1996

EchoGen Emulsion initial trial results in prostate disease revealed

Dec. 12, 1996

FDA gives go-ahead to Hemagen for lupus diagnostic

Dec. 11, 1996

HemispheRx CFS diagnostic receives European patent approval

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...